• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Current Controversies in Prenatal Diagnosis 2: NIPT results suggesting maternal cancer should always be disclosed.

作者信息

Benn Peter, Plon Sharon E, Bianchi Diana W

机构信息

Department of Genetics and Genome Sciences, UCONN Health, Farmington, Connecticut.

Departments of Pediatrics and Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.

出版信息

Prenat Diagn. 2019 Apr;39(5):339-343. doi: 10.1002/pd.5379. Epub 2018 Dec 10.

DOI:10.1002/pd.5379
PMID:30398677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6714972/
Abstract
摘要

相似文献

1
Current Controversies in Prenatal Diagnosis 2: NIPT results suggesting maternal cancer should always be disclosed.产前诊断的当前争议2：无创产前检测（NIPT）结果提示母体癌症时应始终予以披露。
Prenat Diagn. 2019 Apr;39(5):339-343. doi: 10.1002/pd.5379. Epub 2018 Dec 10.
2
Noninvasive Prenatal Testing and Detection of Occult Maternal Malignancies.无创产前检测与隐匿性母体恶性肿瘤的检测
Clin Chem. 2019 Dec;65(12):1484-1486. doi: 10.1373/clinchem.2019.306548. Epub 2019 Oct 11.
3
Current controversies in prenatal diagnosis: Expanded NIPT that includes conditions other than trisomies 13, 18, and 21 should be offered.当前产前诊断的争议：应提供包括 13、18 和 21 三体以外的其他疾病的扩展 NIPT。
Prenat Diagn. 2021 Sep;41(10):1316-1323. doi: 10.1002/pd.5943. Epub 2021 Jun 15.
4
[Maternal Tumor Disease as a Reason for Repeated Test Failure in Cell-Free DNA Screening].[母体肿瘤疾病作为无细胞DNA筛查中重复检测失败的原因]
Z Geburtshilfe Neonatol. 2019 Jun;223(3):179-183. doi: 10.1055/a-0850-0650. Epub 2019 Jun 14.
5
Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.在国民医疗服务体系地区遗传学实验室中实施基于游离DNA的无创产前检测
Genet Res (Camb). 2019 Dec 9;101:e11. doi: 10.1017/S0016672319000119.
6
Incidental finding of maternal sex chromosome aneuploidy from DMD carrier screening and single-nucleotide polymorphism (SNP)-based prenatal cell-free DNA screening.在杜氏肌营养不良症（DMD）携带者筛查和基于单核苷酸多态性（SNP）的产前游离DNA筛查中偶然发现母体性染色体非整倍体。
J Genet Couns. 2025 Jun;34(3):e70050. doi: 10.1002/jgc4.70050.
7
Contribution of maternal mosaicism to false-positive chromosome X loss associated with noninvasive prenatal testing.母体镶嵌现象对与无创性产前检测相关的假阳性 X 染色体丢失的贡献。
J Matern Fetal Neonatal Med. 2022 Dec;35(25):9647-9653. doi: 10.1080/14767058.2022.2050362. Epub 2022 Mar 13.
8
Noninvasive prenatal testing for congenital heart disease - cell-free nucleic acid and protein biomarkers in maternal blood.先天性心脏病的无创产前检测——母血中的游离核酸和蛋白质生物标志物
J Matern Fetal Neonatal Med. 2020 Mar;33(6):1044-1050. doi: 10.1080/14767058.2018.1508437. Epub 2018 Sep 10.
9
Retrospective analysis of the risk factors associated with failure in obtaining effective noninvasive prenatal test results and pregnancy outcomes: a case-control study.回顾性分析与无效无创性产前检测结果和妊娠结局相关的风险因素：病例对照研究。
Expert Rev Mol Diagn. 2022 Mar;22(3):387-394. doi: 10.1080/14737159.2022.2049245. Epub 2022 Mar 9.
10
Non-invasive cell-free fetal DNA testing for aneuploidy: multicenter study of 31 515 singleton pregnancies in southeastern China.无创性游离胎儿 DNA 检测非整倍体：中国东南部 31515 例单胎妊娠的多中心研究。
Ultrasound Obstet Gynecol. 2020 Feb;55(2):242-247. doi: 10.1002/uog.20416. Epub 2020 Jan 8.

引用本文的文献

1
Patients' perspectives on prenatal screening results that suggest maternal cancer: A qualitative analysis.患者对提示母体癌症的产前筛查结果的看法：定性分析。
Prenat Diagn. 2023 Aug;43(9):1101-1109. doi: 10.1002/pd.6406. Epub 2023 Jul 21.
2
Noninvasive Prenatal Testing Using Circulating DNA and RNA: Advances, Challenges, and Possibilities.利用循环 DNA 和 RNA 的无创性产前检测：进展、挑战和可能性。
Annu Rev Biomed Data Sci. 2023 Aug 10;6:397-418. doi: 10.1146/annurev-biodatasci-020722-094144. Epub 2023 May 17.
3
Non-invasive prenatal diagnosis of single gene disorders with enhanced relative haplotype dosage analysis for diagnostic implementation.应用增强相对单体型剂量分析的无创性产前诊断单基因疾病。
PLoS One. 2023 Apr 24;18(4):e0280976. doi: 10.1371/journal.pone.0280976. eCollection 2023.
4
"Overestimated technology - underestimated consequences" - reflections on risks, ethical conflicts, and social disparities in the handling of non-invasive prenatal tests (NIPTs).“高估技术——低估后果”——对非侵入性产前检测（NIPT）处理中的风险、伦理冲突和社会差异的反思。
Med Health Care Philos. 2023 Jun;26(2):271-282. doi: 10.1007/s11019-023-10143-1. Epub 2023 Mar 18.
5
Prenatal DNA Sequencing for Fetal Aneuploidy Also Detects Maternal Cancer: Importance of Timely Workup and Management in Pregnant Women.用于胎儿非整倍体检测的产前DNA测序也能检测出母体癌症：对孕妇进行及时检查和管理的重要性。
J Clin Oncol. 2022 Aug 1;40(22):2398-2401. doi: 10.1200/JCO.22.00733. Epub 2022 Jun 15.
6
More than an Incidentaloma: The Nonreportable NIPT.不止是偶发瘤：不可报告的无创产前检测结果
Case Rep Obstet Gynecol. 2022 Apr 30;2022:2496057. doi: 10.1155/2022/2496057. eCollection 2022.
7
Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies.对常规非侵入性检测数据进行全基因组综合分析可实现癌症预测：一项对超过85000例妊娠的单中心回顾性分析。
EClinicalMedicine. 2021 May 13;35:100856. doi: 10.1016/j.eclinm.2021.100856. eCollection 2021 May.
8
Chances and Challenges of New Genetic Screening Technologies (NIPT) in Prenatal Medicine from a Clinical Perspective: A Narrative Review.从临床角度看产前医学中新的基因筛查技术（NIPT）的机遇与挑战：叙事性综述。
Genes (Basel). 2021 Mar 29;12(4):501. doi: 10.3390/genes12040501.
9
Diagnosis of maternal Hodgkin lymphoma following abnormal findings at noninvasive prenatal screening test (NIPT): Report of two cases.非侵入性产前筛查试验（NIPT）出现异常结果后诊断为母亲霍奇金淋巴瘤：两例报告
Clin Case Rep. 2021 Jan 13;9(3):1066-1071. doi: 10.1002/ccr3.3593. eCollection 2021 Mar.
10
Chromosomal mosaicism: Origins and clinical implications in preimplantation and prenatal diagnosis.染色体嵌合体：在胚胎植入前和产前诊断中的起源和临床意义。
Prenat Diagn. 2021 Apr;41(5):631-641. doi: 10.1002/pd.5931. Epub 2021 Mar 22.

本文引用的文献

1
Sequencing of Circulating Cell-free DNA during Pregnancy.孕期循环游离 DNA 测序。
N Engl J Med. 2018 Aug 2;379(5):464-473. doi: 10.1056/NEJMra1705345.
2
Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.《国家癌症报告：第一部分：全国癌症统计数据》
Cancer. 2018 Jul 1;124(13):2785-2800. doi: 10.1002/cncr.31551. Epub 2018 May 22.
3
Updates on Translational Research on Prevention of Polyps and Colorectal Cancer.息肉与结直肠癌预防的转化研究进展
Clin Colon Rectal Surg. 2018 May;31(3):153-160. doi: 10.1055/s-0037-1602235. Epub 2018 May 1.
4
Psychological issues and construction of the mother-child relationship in women with cancer during pregnancy: a perspective on current and future directions.妊娠期癌症女性的心理问题与母婴关系构建：当前和未来方向的视角。
BMC Psychol. 2018 Mar 16;6(1):10. doi: 10.1186/s40359-018-0224-5.
5
Maternal Malignancy Evaluation After Discordant Cell-Free DNA Results.不一致的游离胎儿 DNA 检测结果后对母体恶性肿瘤的评估。
Obstet Gynecol. 2018 Mar;131(3):464-468. doi: 10.1097/AOG.0000000000002474.
6
Genome-wide non-invasive prenatal screening for all cytogenetically visible imbalances.针对所有细胞遗传学可见失衡的全基因组无创产前筛查。
Ultrasound Obstet Gynecol. 2018 Apr;51(4):429-433. doi: 10.1002/uog.19014.
7
Unusual Prenatal Genomic Results Provide Proof-of-Principle of the Liquid Biopsy for Cancer Screening.异常的产前基因组结果为癌症筛查的液体活检提供了原理验证。
Clin Chem. 2018 Feb;64(2):254-256. doi: 10.1373/clinchem.2017.282459. Epub 2017 Dec 13.
8
Cherchez la femme: maternal incidental findings can explain discordant prenatal cell-free DNA sequencing results.寻找病因：母体偶然发现的异常可解释不一致的产前游离 DNA 测序结果。
Genet Med. 2018 Sep;20(9):910-917. doi: 10.1038/gim.2017.219. Epub 2017 Dec 7.
9
Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing.在无创性产前检测中偶然发现的母体肿瘤。
Clin Chem. 2018 Feb;64(2):329-335. doi: 10.1373/clinchem.2017.277517. Epub 2017 Oct 5.
10
Prenatal anxiety effects: A review.产前焦虑的影响：综述
Infant Behav Dev. 2017 Nov;49:120-128. doi: 10.1016/j.infbeh.2017.08.008. Epub 2017 Sep 5.